NOUVEAU COMPOSÉ, SEL PHARMACEUTIQUEMENT ACCEPTABLE OU ISOMÈRE OPTIQUE DE CELUI-CI, PROCÉDÉ DE PRÉPARATION DE CELUI-CI ET COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION OU LE TRAITEMENT DE MALADIES VIRALES CONTENANT CELUI-CI EN TANT QUE PRINCIPE ACTIF
Korea Research Institute of Chemical Technology;Katholieke Universiteit Leuven K.U. Leuven R&D
发明人:
申请号：
EP13862055.4
公开号：
EP2933254A1
申请日:
2013.12.16
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to a novel compound, to a pharmaceutically acceptable salt or optical isomer thereof, to a method for preparing same, and to a pharmaceutical composition for the prevention or treatment of viral diseases containing same as an active ingredient. The novel compound according to the present invention not only has low cytotoxicity but also has excellent antiviral activity against picornavirus such as coxsackievirus, enterovirus, echovirus, poliovirus and rhinovirus, and thus can be effectively used as a pharmaceutical composition for the prevention or treatment of viral diseases such as infantile paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myitis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinus infection, or otitis media.
